HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

[1]  Jean-Michel Pawlotsky,et al.  EASL Recommendations on Treatment of Hepatitis C 2018. , 2018, Journal of hepatology.

[2]  J. Pawlotsky,et al.  Clinical Utility of HCV Core Antigen Detection and Quantification in the Diagnosis and Management of Patients with Chronic Hepatitis C Receiving an All-Oral, Interferon-Free Regimen , 2016, Antiviral therapy.

[3]  Geoffrey Dusheiko,et al.  Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. , 2017, The lancet. Gastroenterology & hepatology.

[4]  S. Taylor-Robinson,et al.  Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania , 2017, Journal of the International AIDS Society.

[5]  D. Nelson,et al.  Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. , 2017, Annals of internal medicine.

[6]  J. Pawlotsky,et al.  EASL Recommendations on Treatment of Hepatitis C 2016. , 2017, Journal of hepatology.

[7]  A. Aghemo,et al.  Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  M. Manns,et al.  Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens. , 2016, Journal of hepatology.

[9]  J. M. Freiman,et al.  Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection , 2016, Annals of Internal Medicine.

[10]  S. Kassim,et al.  The accuracy and cost‐effectiveness of hepatitis C core antigen assay in the monitoring of anti‐viral therapy in patients with chronic hepatitis C genotype 4 , 2015, Alimentary pharmacology & therapeutics.

[11]  P. Paci,et al.  The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[13]  T. Wong,et al.  Cost-effectiveness of screening for hepatitis C in Canada , 2015, Canadian Medical Association Journal.

[14]  D. Otelea,et al.  Clinical usefulness of HCV core antigen assay for the management of patients with chronic hepatitis C. , 2014, Journal of gastrointestinal and liver diseases : JGLD.

[15]  H. Tillmann.  Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment. , 2014, World journal of gastroenterology.

[16]  M. Buti,et al.  Historical epidemiology of hepatitis C virus (HCV) in selected countries , 2014, Journal of viral hepatitis.

[17]  A. Huber,et al.  Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  A. Berger,et al.  Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[19]  M. Manns,et al.  Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[20]  R. Chung,et al.  Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  M. Mizokami,et al.  High stability of enzyme immunoassay for hepatitis C virus core antigen-evaluation before and after incubation at room temperature. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.